(4Z,7Z,10Z,13Z,16Z,19Z)-N-[(2S)-1-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]-1-oxopropan-2-yl]docosa-4,7,10,13,16,19-hexaenamide

C38H46N4O6 — CID 70945152

IUPAC(4Z,7Z,10Z,13Z,16Z,19Z)-N-[(2S)-1-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]-1-oxopropan-2-yl]docosa-4,7,10,13,16,19-hexaenamide
SMILESCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)N[C@@H](C)C(=O)Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O
InChIInChI=1S/C38H46N4O6/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-25-32(43)39-28(2)35(45)40-30-24-22-23-29-34(30)38(48)42(37(29)47)31-26-27-33(44)41-36(31)46/h4-5,7-8,10-11,13-14,16-17,19-20,22-24,28,31H,3,6,9,12,15,18,21,25-27H2,1-2H3,(H,39,43)(H,40,45)(H,41,44,46)/b5-4-,8-7-,11-10-,14-13-,17-16-,20-19-/t28-,31?/m0/s1
InChIKeyZWIRAIONLINJMR-BHYBJQEOSA-N
MW654.81 g/mol
LogP6.01
Rot. Bonds18

About (4Z,7Z,10Z,13Z,16Z,19Z)-N-[(2S)-1-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]-1-oxopropan-2-yl]docosa-4,7,10,13,16,19-hexaenamide

(4Z,7Z,10Z,13Z,16Z,19Z)-N-[(2S)-1-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]-1-oxopropan-2-yl]docosa-4,7,10,13,16,19-hexaenamide (PubChem CID 70945152) has the molecular formula C38H46N4O6 and a molecular weight of 654.81 g/mol. Its IUPAC name is (4Z,7Z,10Z,13Z,16Z,19Z)-N-[(2S)-1-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]-1-oxopropan-2-yl]docosa-4,7,10,13,16,19-hexaenamide.

Molecular Properties

Compound Name(4Z,7Z,10Z,13Z,16Z,19Z)-N-[(2S)-1-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]-1-oxopropan-2-yl]docosa-4,7,10,13,16,19-hexaenamide
PubChem CID70945152
Molecular FormulaC38H46N4O6
Molecular Weight654.81 g/mol
Exact Mass654.34
IUPAC Name(4Z,7Z,10Z,13Z,16Z,19Z)-N-[(2S)-1-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]-1-oxopropan-2-yl]docosa-4,7,10,13,16,19-hexaenamide
SMILESCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)N[C@@H](C)C(=O)Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O
InChIInChI=1S/C38H46N4O6/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-25-32(43)39-28(2)35(45)40-30-24-22-23-29-34(30)38(48)42(37(29)47)31-26-27-33(44)41-36(31)46/h4-5,7-8,10-11,13-14,16-17,19-20,22-24,28,31H,3,6,9,12,15,18,21,25-27H2,1-2H3,(H,39,43)(H,40,45)(H,41,44,46)/b5-4-,8-7-,11-10-,14-13-,17-16-,20-19-/t28-,31?/m0/s1
InChIKeyZWIRAIONLINJMR-BHYBJQEOSA-N
XLogP6.01
TPSA141.75 Ų
H-Bond Donors3
H-Bond Acceptors6
Rotatable Bonds18
Heavy Atoms48
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500654.81
LogP ≤ 56.01
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze (4Z,7Z,10Z,13Z,16Z,19Z)-N-[(2S)-1-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]-1-oxopropan-2-yl]docosa-4,7,10,13,16,19-hexaenamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (4Z,7Z,10Z,13Z,16Z,19Z)-N-[(2S)-1-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]-1-oxopropan-2-yl]docosa-4,7,10,13,16,19-hexaenamide?
The IUPAC name of (4Z,7Z,10Z,13Z,16Z,19Z)-N-[(2S)-1-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]-1-oxopropan-2-yl]docosa-4,7,10,13,16,19-hexaenamide (CID 70945152) is (4Z,7Z,10Z,13Z,16Z,19Z)-N-[(2S)-1-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]-1-oxopropan-2-yl]docosa-4,7,10,13,16,19-hexaenamide.
What is the SMILES notation for (4Z,7Z,10Z,13Z,16Z,19Z)-N-[(2S)-1-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]-1-oxopropan-2-yl]docosa-4,7,10,13,16,19-hexaenamide?
The canonical SMILES for (4Z,7Z,10Z,13Z,16Z,19Z)-N-[(2S)-1-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]-1-oxopropan-2-yl]docosa-4,7,10,13,16,19-hexaenamide is CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)N[C@@H](C)C(=O)Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O.
What is the InChIKey of (4Z,7Z,10Z,13Z,16Z,19Z)-N-[(2S)-1-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]-1-oxopropan-2-yl]docosa-4,7,10,13,16,19-hexaenamide?
The InChIKey is ZWIRAIONLINJMR-BHYBJQEOSA-N. The full InChI is InChI=1S/C38H46N4O6/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-25-32(43)39-28(2)35(45)40-30-24-22-23-29-34(30)38(48)42(37(29)47)31-26-27-33(44)41-36(31)46/h4-5,7-8,10-11,13-14,16-17,19-20,22-24,28,31H,3,6,9,12,15,18,21,25-27H2,1-2H3,(H,39,43)(H,40,45)(H,41,44,46)/b5-4-,8-7-,11-10-,14-13-,17-16-,20-19-/t28-,31?/m0/s1.
What are the key properties of (4Z,7Z,10Z,13Z,16Z,19Z)-N-[(2S)-1-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]-1-oxopropan-2-yl]docosa-4,7,10,13,16,19-hexaenamide?
(4Z,7Z,10Z,13Z,16Z,19Z)-N-[(2S)-1-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]-1-oxopropan-2-yl]docosa-4,7,10,13,16,19-hexaenamide has a molecular weight of 654.81 g/mol, XLogP of 6.01, 18 rotatable bonds, 3 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (4Z,7Z,10Z,13Z,16Z,19Z)-N-[(2S)-1-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]-1-oxopropan-2-yl]docosa-4,7,10,13,16,19-hexaenamide is sourced from PubChem (CID 70945152), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).